Masks prevent people from transmitting the coronavirus to others, scientists now agree. But a new trial failed to document protection from the virus among the wearers.
Author: Gina Kolata
Remdesivir Coronavirus Trial: Federal Scientists Finally Publish Data
A clinical trial led to the authorization of the only drug shown to work in Covid-19 patients. But until now, few experts had seen the numbers.
Uncertain Results in Study of Convalescent Serum for Covid-19
Do antibodies from patients who have recovered actually help those struggling with the disease?
How Pandemics End
An infectious outbreak can conclude in more ways than one, historians say. But for whom does it end, and who gets to decide?
How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected
The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
Remdesivir Shows Modest Benefits in Coronavirus Trial
Hope soared nonetheless. The F.D.A. is likely to issue an emergency approval, a senior official said.
Why Are Some People So Much More Infectious Than Others?
Solving the mystery of “superspreaders” could help control the coronavirus pandemic.
At the Center of a Storm: The Search for a Proven Coronavirus Treatment
Taking an experimental drug can be worse than taking nothing at all, warns Dr. Andre Kalil: “You are treating emotion.”
A Heart Attack? No, It Was the Coronavirus
Cardiologists are seeing infected patients whose worst symptoms are not respiratory, but cardiac.